Literature DB >> 23387772

Noninvasive evaluation of vaginal fibrosis following radiotherapy for gynecologic malignancies: a feasibility study with ultrasound B-mode and Nakagami parameter imaging.

Xiaofeng Yang1, Peter Rossi, Deborah Watkins Bruner, Srini Tridandapani, Joseph Shelton, Tian Liu.   

Abstract

PURPOSE: This study's purpose is to develop a quantitative ultrasound technology to evaluate radiation-induced vaginal fibrosis. Radiation therapy (RT) is an important treatment modality for most gynecologic (GYN) malignancies. However, vaginal fibrosis is a common chronic side-effect, affecting 80% of women post vaginal or pelvic RT. Vaginal fibrosis leads to pain, sexual dysfunction, and poor quality of life.
METHODS: The authors propose a novel ultrasound approach that combines conventional B-mode imaging with Nakagami parameter imaging to quantitatively evaluate post-RT vaginal injury. From the B-mode image, vaginal wall thickness and echo intensity were calculated to capture the anatomy and echogenicity of the vaginal wall. From Nakagami imaging, two statistical parameters, Nakagami probability density function (PDF) and Nakagami shape, were computed to measure the concentration and arrangement of vaginal tissue microstructures. This novel ultrasound imaging concept was investigated in a pilot study of 12 patients, who were previously diagnosed and treated for endometrial cancer. The 12 participants were stratified into two groups: (1) the control group consisted of 6 patients who received surgery (hysterectomy) alone and (2) the post-RT group consisted of 6 patients who received surgery plus radiotherapy, with a follow-up time of 12-38 months. Each participant underwent one transvaginal ultrasound study (6 MHz). Three transverse images of the anterior vaginal wall were acquired in a 2 cm step from the apex (vaginal cuff) to the introitus (vagina opening). The vaginal wall thickness, echo intensity, Nakagami PDF, and Nakagami parameter were calculated to evaluate radiation-induced vaginal fibrosis.
RESULTS: Both B-mode and Nakagami methods showed significant differences in parameters between the post-RT and nonirradiated vaginal walls. Compared with the control group, the vaginal wall thickness of the post-RT group increased by 153.2% (p = 0.002), the echo intensity increased by 11.6% (p = 0.017), the Nakagami PDF increased by 72.3% (p < 0.001), and the Nakagami shape valued increased by 33.0% (p = 0.028).
CONCLUSIONS: Vaginal fibrosis appears to be associated with a thickened vaginal wall, higher echogenicity, as well as increased Nakagami PDF and shape parameters. This pilot study shows the authors' quantitative ultrasound approach combining B-mode and Nakagami imaging is a promising imaging method to evaluate vaginal fibrosis. This imaging method may be useful as physicians try to address vaginal toxicities and sexual dysfunction in women after radiotherapy for GYN malignancies.

Entities:  

Mesh:

Year:  2013        PMID: 23387772      PMCID: PMC3555916          DOI: 10.1118/1.4773872

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  19 in total

1.  Ultrasonic tissue characterization using a generalized Nakagami model.

Authors:  P M Shankar
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2001-11       Impact factor: 2.725

2.  Classification of ultrasonic B-mode images of breast masses using Nakagami distribution.

Authors:  P M Shankar; V A Dumane; J M Reid; V Genis; F Forsberg; C W Piccoli; B B Goldberg
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2001-03       Impact factor: 2.725

3.  Point: Vaginal brachytherapy should be a standard adjuvant treatment for intermediate-risk endometrial cancer.

Authors:  Remi A Nout; Carien L Creutzberg
Journal:  Brachytherapy       Date:  2011 Jan-Feb       Impact factor: 2.362

4.  Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study.

Authors:  S M Bentzen; H D Thames; M Overgaard
Journal:  Radiother Oncol       Date:  1989-07       Impact factor: 6.280

5.  Statistical properties of radio-frequency and envelope-detected signals with applications to medical ultrasound.

Authors:  R F Wagner; M F Insana; D G Brown
Journal:  J Opt Soc Am A       Date:  1987-05       Impact factor: 2.129

6.  A model for ultrasonic scattering from tissues based on the K distribution.

Authors:  P M Shankar
Journal:  Phys Med Biol       Date:  1995-10       Impact factor: 3.609

7.  Using ultrasound Nakagami imaging to assess liver fibrosis in rats.

Authors:  Ming-Chih Ho; Jen-Jen Lin; Yu-Chen Shu; Chiung-Nien Chen; King-Jen Chang; Chien-Cheng Chang; Po-Hsiang Tsui
Journal:  Ultrasonics       Date:  2011-08-22       Impact factor: 2.890

8.  Assessing women's sexuality after cancer therapy: checking assumptions with the focus group technique.

Authors:  D W Bruner; C P Boyd
Journal:  Cancer Nurs       Date:  1999-12       Impact factor: 2.592

9.  Ultrasonic Nakagami imaging: a strategy to visualize the scatterer properties of benign and malignant breast tumors.

Authors:  Po-Hsiang Tsui; Chih-Kuang Yeh; Yin-Yin Liao; Chien-Cheng Chang; Wen-Hung Kuo; King-Jen Chang; Chiung-Nien Chen
Journal:  Ultrasound Med Biol       Date:  2009-12-16       Impact factor: 2.998

10.  Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.

Authors:  D W Bruner; R Lanciano; M Keegan; B Corn; E Martin; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-11-15       Impact factor: 7.038

View more
  2 in total

1.  A Computer-Aided Diagnosis Scheme For Detection Of Fatty Liver In Vivo Based On Ultrasound Kurtosis Imaging.

Authors:  Hsiang-Yang Ma; Zhuhuang Zhou; Shuicai Wu; Yung-Liang Wan; Po-Hsiang Tsui
Journal:  J Med Syst       Date:  2015-11-12       Impact factor: 4.460

2.  Evaluation of thrombolysis by using ultrasonic imaging: an in vitro study.

Authors:  Jui Fang; Po-Hsiang Tsui
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.